Aoki S, Kubo E, Nakamura S, Tsuzuki A, Tsuzuki S, Takahashi Y, Akagi Y
Department of Ophthalmology, Fukui Medical University, Japan.
Jpn J Ophthalmol. 1998 Jul-Aug;42(4):256-61. doi: 10.1016/s0021-5155(98)00017-3.
Conjunctival squamous cell carcinoma (SCC) can develop from carcinoma in situ or severe dysplasia known as conjunctival intraepithelial neoplasia (CIN). Conjunctival intraepithelial neoplasia and SCC are histopathologically well-defined conditions. However, it is difficult to determine the grading of dysplasia by clinical morphologic findings. Recently, proliferating cell nuclear antigen (PCNA) immunostaining, p53 immunostaining, and argyrophilic nucleolar organizer regions (AgNORs) staining have been established as valuable means of studying the biologic behavior of malignant cells. In the present study, these three staining techniques were used to examine histologic preparations of three conjunctival dysplasia and one SCC lesion. Five conjunctival tumor samples were obtained from four patients between July 1993 and October 1995. Following formalin fixation and embedding in paraffin, PCNA, and p53 immunostaining and AgNORs staining was performed with all tissue specimens. The PCNA-positive rate was the highest in SCC, followed by severe dysplasia and mild dysplasia. The p53-positive rate was the highest in severe dysplasia, followed by mild dysplasia, and negative in SCC. The AgNORs-count increased as malignancy advanced. These staining methods, which are markers for proliferative potency and cell differentiation, will be useful for early detection of changes in malignancy and will aid in decisions on treatment and prognosis.
结膜鳞状细胞癌(SCC)可由原位癌或称为结膜上皮内瘤变(CIN)的重度发育异常发展而来。结膜上皮内瘤变和SCC在组织病理学上是明确界定的病症。然而,通过临床形态学表现很难确定发育异常的分级。近来,增殖细胞核抗原(PCNA)免疫染色、p53免疫染色和嗜银核仁组成区(AgNORs)染色已成为研究恶性细胞生物学行为的有价值手段。在本研究中,运用这三种染色技术对三个结膜发育异常和一个SCC病变的组织学标本进行检查。1993年7月至1995年10月期间从4例患者获取了5份结膜肿瘤样本。在福尔马林固定并石蜡包埋后,对所有组织标本进行PCNA、p53免疫染色和AgNORs染色。PCNA阳性率在SCC中最高,其次是重度发育异常和轻度发育异常。p53阳性率在重度发育异常中最高,其次是轻度发育异常,在SCC中为阴性。随着恶性程度进展,AgNORs计数增加。这些作为增殖能力和细胞分化标志物的染色方法,将有助于早期发现恶性程度的变化,并有助于治疗决策和预后判断。